DEUTSCHE BANK AG\
BankPosition in VNDA — Vanda Pharmaceuticals Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in VNDA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$321,581
-$76,248 QoQ
Shares Held
52,546
-8.7% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 172 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. VNDA ranks #207 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in VNDA
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $321,581 | 52,546 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $397,829 | 57,573 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $443,504 | 50,284 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $252,673 | 50,636 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $286,494 | 62,417 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $336,109 | 70,169 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $212,818 | 45,377 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $195,891 | 34,671 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $144,972 | 35,273 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $137,576 | 32,601 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $171,724 | 39,751 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $222,932 | 33,829 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $280,310 | 41,283 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $337,854 | 45,718 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $388,302 | 39,302 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $513,966 | 47,153 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $613,791 | 54,270 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $913,360 | 58,213 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $1,048,178 | 61,154 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 ALXN | — | 2,217,236 | Shares | Defined | 2021-08-11 | |
| 2021-06-30 | $3,215,528 | 149,490 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 ALXN | — | 2,279,545 | Shares | Other | 2021-05-13 | |
| 2021-03-31 | $2,332,228 | 155,275 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 ALXN | — | 1,309,305 | Shares | Defined | 2021-02-16 | |
| 2020-12-31 | $870,077 | 66,216 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 ALXN | — | 1,487,899 | Shares | Defined | 2020-11-12 | |
| 2020-09-30 | $486,572 | 50,370 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 ALXN | — | 1,448,497 | Shares | Defined | 2020-08-13 | |
| 2020-06-30 | $1,064,010 | 93,008 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 ALXN | — | 1,483,979 | Shares | Other | 2020-05-14 | |
| 2020-03-31 | $4,789,893 | 462,345 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||